参考文献/References:
[1].中华医学会心血管病学分会心血管病影像学组,稳定性冠心病无创影像检查路径的专家共识写作组. 稳定性冠心病无创影像检查路径的专家共识[J]. 中国介入心脏病学杂志,2017,25(10):541-549.
[2].Truong VT,Palmer C,Wolking S,et al. Normal left atrial strain and strain rate using cardiac magnetic resonance feature tracking in healthy volunteers[J].?Eur Heart J Cardiovasc Imaging,2020,21(4):446-453.
[3].Xu J,Yang W,Zhao S,et al. State-of-the-art myocardial strain by CMR feature tracking:clinical applications and future perspectives[J].?Eur Radiol,2022,32(8):5424-5435.
[4].Flachskampf FA,Blankstein R,Grayburn PA,et al. Global longitudinal shortening:a positive step towards reducing confusion surrounding global?longitudinal strain[J].JACC Cardiovasc Imaging,2019,12(8 Pt 1):1566-1567.
[5].Cau R,Bassareo P,Suri JS,et al. The emerging role of atrial strain assessed by cardiac MRI in different cardiovascular settings,an up-to-date review[J].?Eur Radiol,2022,32(7):4384-4394.
[6].Truong VT,Palmer C,Young M,et al. Right atrial deformation using cardiovascular magnetic resonance myocardial feature tracking compared with two-dimensional speckle tracking echocardiography in healthy volunteers[J].Sci Rep,2020,10(1):5237.
[7].Tamarappoo B,Samuel TJ,Elboudwarej O,et al. Left ventricular circumferential strain and coronary microvascular dysfunction:a report from the Women’s Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) project[J].Int J Cardiol,2021,327:25-30.
[8].Overhoff D,Ansari U,Hohneck A,et al. Prediction of cardiac events with non-contrast magnetic resonance feature tracking in patients with ischaemic cardiomyopathy[J].ESC Heart Fail,2022,9(1):574-584.
[9].Vietheer J,Lehmann L,Unbehaun C,et al. CMR-derived myocardial strain analysis differentiates ischemic and dilated cardiomyopathy—A propensity score-matched study[J].?Int J Cardiovasc Imaging,2021,DOI:10.1007/s10554-021-02469-9.Online ahead of print.
[10].Tantawy SW,Mohammad SA,Osman AM,et al. Strain analysis using feature tracking cardiac magnetic resonance (FT-CMR) in the assessment of myocardial viability in chronic ischemic patients[J].?Int J Cardiovasc Imaging,2021,37(2):587-596.
[11].Ochs A,Riffel J,Ochs MM,et al. Myocardial mechanics in dilated cardiomyopathy:prognostic value of left ventricular torsion and strain[J].?J Cardiovasc Magn Reson,2021,23(1):136.
[12].Tang HS,Kwan CT,He J,et al. Prognostic utility of cardiac mri myocardial strain parameters in patients with ischemic and nonischemic dilated cardiomyopathy:a multicenter study[J].?AJR Am J Roentgenol,2023,220(4):524-538.
[13].Mazurkiewicz ?,Petryka J,Spiewak M ,et al. Biventricular mechanics in prediction of severe myocardial fibrosis in patients with dilated cardiomyopathy:CMR study[J]. Eur J Radiol,2017,91:71-81.
[14].Cittar M,Cipriani A,Merlo M,et al. Prognostic significance of feature-tracking right ventricular global longitudinal strain in non-ischemic dilated cardiomyopathy[J].Front Cardiovasc Med,2021,8:765274.
[15].Maron BJ,Desai MY,Nishimura RA,et al. Diagnosis and evaluation of hypertrophic?cardiomyopathy:JACC state-of-the-art review[J].J Am Coll Cardiol,2022,79(4):372-389.
[16].Yang L,Zhang L,Cao S,et al. Advanced myocardial characterization in hypertrophic cardiomyopathy:feasibility of CMR-based feature tracking strain analysis in a case-control study[J].Eur Radiol,2020,30(11):6118-6128.
[17].Liu S,Li Y,Zhao Y,et al. The combination of feature tracking and late gadolinium enhancement for identification between hypertrophic cardiomyopathy and hypertensive heart disease[J].Front Cardiovasc Med,2022,9:865615.
[18].Zhang L,Wan Y,He B,et al. Left ventricular strain patterns and their relationships with cardiac biomarkers in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction[J].?Front Cardiovasc Med,2022,9:963110.
[19].Rezaeian N,Hosseini L,Omidi N,et al. Feature-tracking cardiac magnetic resonance method:a valuable marker of replacement fibrosis in hypertrophic cardiomyopathy[J].Pol J Radiol,2022,87:e263-e270.
[20].Song Y,Bi X,Chen L,et al. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy:associated with histological myocardial fibrosis and ventricular arrhythmias[J].?Eur Heart J Cardiovasc Imaging,2022,23(8):1006-1015.
[21].Rapezzi C,Aimo A,Barison A,et al. Restrictive cardiomyopathy:definition and diagnosis[J].Eur Heart J,2022,43(45):4679-4693.
[22].Yang Z,Wang H,Chang S,et al. Left ventricular strain-curve morphology to distinguish between constrictive pericarditis and restrictive cardiomyopathy[J].ESC Heart Fail,2021,8(6):4863-4872.
[23].Stojanovska J,Topaloglu N,Fujikura K,et al. Decreased left atrial reservoir strain is associated with adverse outcomes in restrictive cardiomyopathy[J].J Clin Med,2022,11(14):4116.
[24].Vigneault DM,te Riele AS,James CA,et al. Right ventricular strain by MR quantitatively identifies regional dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy[J].J Magn Reson Imaging,2016,43(5):1132-1139.
[25].Prati G,Vitrella G,Allocca G,et al. Right ventricular strain and dyssynchrony assessment in arrhythmogenic right ventricular cardiomyopathy:cardiac magnetic resonance feature-tracking study[J].Circ Cardiovasc Imaging,2015,8(11):e003647.
[26].Heermann P,Fritsch H,Koopmann M,et al. Biventricular myocardial strain analysis using cardiac magnetic resonance feature tracking (CMR-FT) in patients with distinct types of right ventricular diseases comparing arrhythmogenic right ventricular cardiomyopathy (ARVC),right ventricular outflow-tract tachycardia (RVOT-VT),and Brugada syndrome (BrS)[J].?Clin Res Cardiol,2019,108(10):1147-1162.
[27].Chen X,Li L,Cheng H,et al. Early left ventricular involvement detected by cardiovascular magnetic resonance feature tracking in arrhythmogenic right ventricular cardiomyopathy:the effects of left ventricular late gadolinium enhancement and right ventricular dysfunction[J].J Am Heart Assoc,2019,8(17):e012989.
[28].Anwer S,Guastafierro F,Erhart L,et al. Right atrial strain and cardiovascular outcome in arrhythmogenic right ventricular cardiomyopathy[J].Eur Heart J Cardiovasc Imaging,2022,23(7):970-978.
[29].Porcari A,Merlo M,Crosera L,et al. Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study[J].?Clin Res Cardiol,2020,109(7):869-880.
[30].Bozkurt B,Coats AJS,Tsutsui H,et al. Universal definition and classification of heart failure:a report of the Heart Failure Society of America,Heart Failure Association of the European Society of Cardiology,Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure:Endorsed by the Canadian Heart Failure Society,Heart Failure Association of India,Cardiac Society of Australia and New Zealand,and Chinese Heart Failure Association[J].Eur J Heart Fail,2021,23(3):352-380.
[31].Romano S,Judd RM,Kim RJ,et al. Feature-tracking global longitudinal strain predicts mortality in patients with preserved ejection fraction:a multicenter study[J].JACC Cardiovasc Imaging,2020,13(4):940-947.
[32].He J,Yang W,Wu W,et al. Early diastolic longitudinal strain rate at MRI and outcomes in heart failure with preserved ejection fraction[J].?Radiology,2022,302(1):E5.
[33].Xu L,Pagano JJ,Haykowksy MJ,et al. Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance:not all layers are the same[J].?J Cardiovasc Magn Reson,2020,22(1):81.
[34].He J,Sirajuddin A,Li S,et al. Heart failure with preserved ejection fraction in hypertension patients:a myocardial MR strain study[J].J Magn Reson Imaging,2021,53(2):527-539.
[35].Jain S,Kuriakose D,Edelstein I,et al. Right atrial phasic function in heart?failure with preserved and reduced ejection fraction[J].JACC Cardiovasc Imaging,2019,12(8 Pt 1):1460-1470.
[36].Yang Y,Yin G,Jiang Y,et al.Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging:a feasibility and reproducibility study[J].?J Cardiovasc Magn Reson,2020,22(1):1.
[37].Sagris M,Vardas EP,Theofilis P,et al. Atrial fibrillation:pathogenesis,predisposing factors,and genetics[J].Int J Mol Sci,2021,23(1):6.
[38].Goette A,Kalman JM,Aguinaga L,et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies:definition,characterisation,and clinical implication[J].J Arrhythm,2016,32(4):247-278.
[39].Hou J,Sun Y,Zhang L,et al. Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging[J].Clin Cardiol,2022,45(5):527-535.
[40].Wang Y,Gao H,Li Y,et al. Estimating bilateral atrial function by cardiovascular magnetic resonance feature tracking in patients with paroxysmal atrial fibrillation[J].?J Vis Exp,2022 Jul 20,(185).DOI: 10.3791/63598.
[41].Zachos P,Nevras V,Milaras N,et al. The value of myocardial strain imaging in the evaluation of patients with repaired tetralogy of Fallot:a review of the literature[J].?Heart Fail Rev,2023,28(1):97-112.
[42].Schuster A,Backhaus SJ,Stiermaier T,et al. Impact of right atrial physiology on heart failure and adverse events after myocardial infarction[J]. J Clin Med,2020,9(1):210.
[43].van Mourik MJW,Artola Arita V,Lyon A,et al. Association between comorbidities and left and right atrial dysfunction in patients with paroxysmal atrial fibrillation:analysis of AF-RISK[J].Int J Cardiol,2022,360:29-35.
[44].Cau R,Bassareo P,Caredda G,et al. Atrial strain by feature-tracking cardiac magnetic resonance imaging in Takotsubo cardiomyopathy. Features,feasibility,and reproducibility[J].Can Assoc Radiol J,2022,73(3):573-580.
[45].Dobrovie M,Barreiro-Pérez M,Curione D,et al. Inter-vendor reproducibility and accuracy of segmental left ventricular strain measurements using CMR feature tracking[J].?Eur Radiol,2019,29(12):6846-6857.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(10):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(10):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(10):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(10):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(10):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[6]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(10):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[7]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(10):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[8]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[9]吴洋.左室心肌致密化不全的心脏磁共振诊断[J].心血管病学进展,2019,(5):673.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.004]
WU Yang.Diagnosis of Left Ventricular Non-compaction Cardiomyopathy With Cardiac Magnetic Resonance Imaging[J].Advances in Cardiovascular Diseases,2019,(10):673.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.004]
[10]徐源蔚 陈玉成.心脏磁共振在检测自身免疫性风湿疾病心脏受累中的应用进展[J].心血管病学进展,2019,(5):676.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.005]
XU Yuanwei,CHEN Yucheng.Advances in the Application of Cardiac Magnetic Resonance in Detecting Cardiac Involvement in Autoimmune Rheumatic Disease[J].Advances in Cardiovascular Diseases,2019,(10):676.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.005]
[11]倪金荣 雷军强.心肌纤维化的无创影像诊断进展[J].心血管病学进展,2021,(11):1016.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
NI Jinrong,LEI Junqiang.Noninvasive Imaging Diagnosis of Myocardial Fibrosis[J].Advances in Cardiovascular Diseases,2021,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
[12]熊子衿 李晓欢 徐婷 颜梅 许华燕.心脏脂肪沉积机制及相关心血管疾病研究进展[J].心血管病学进展,2023,(7):607.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.008]
XIONG Zijin,LI Xiaohuan,XU TingYAN Mei,et al.CTMRIMechanism of cardiac fat deposition and the research progression of related cardiovascular diseases[J].Advances in Cardiovascular Diseases,2023,(10):607.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.008]